Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.
Lisa Jane WoodhouseJason Philip AppletonSandeep AnkolekarTimothy J EnglandGrant MairKeith MuirChristopher I PriceStuart PocockMarc RandallThompson G RobinsonChristine RoffeElse C SandsetJeffrey L SaverAloysius Niroshan SiriwardenaNikola SpriggJoanna M WardlawPhilip M Bathnull nullPublished in: BMJ neurology open (2023)
ISRCTN26986053.
Keyphrases
- phase iii
- placebo controlled
- double blind
- open label
- clinical trial
- phase ii
- study protocol
- liver failure
- emergency medical
- atrial fibrillation
- cardiac arrest
- respiratory failure
- high resolution
- aortic dissection
- drug induced
- mass spectrometry
- metabolic syndrome
- cerebral ischemia
- mechanical ventilation
- acute respiratory distress syndrome
- weight loss